Another “Holy Grail” being touted for diagnosis of high-risk prostate cancer: an update

We have now been able to track down a link to detailed information about the article by Yu et al. referred to in yesterday’s commentary under the same heading. … READ MORE …

Another “Holy Grail” being touted for diagnosis of high-risk prostate cancer

Another new test — this time (supposedly) reported on-line in the American Journal of Pathology (and scheduled for publication in the June issue of that journal) — has suggested that monitoring genetic variation may be helpful in predicting risk from specific types of prostate cancer. If one is to believe the report in today’s Pittsburgh Post-Gazette, the new test ‘could represent “the Holy Grail of prostate cancer” by specifying from the start whether aggressive treatment is necessary’ … READ MORE …

CNV analysis hints at hereditary susceptibilities for prostate cancer

An new article on line in the Proceedings of the National Academy of Sciences or PNAS has further extended our understanding of the genetic and inheritable factors that may predispose individual patients to higher risk for clinically significant and aggressive forms of prostate cancer … READ MORE …